Pediatric Vaccine Market 2027 By Type, Technology, Application and Geography | The Insight Partners

Pediatric Vaccine Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Type (Monovalent, Multivalent); Technology (Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies); Application (Infectious Disease, Allergy, Other Applications) and Geography

Report Code: TIPRE00008681 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

The pediatric vaccine is used to strengthen the immune system of children during their developing phase. It is mandatory to immunize children with vaccines to prevent incidences of chronic diseases such as Hepatitis B, Measles, and infectious diseases, and others. Children are injected with a vaccine until they reach their adolescence phase.

MARKET DYNAMICS

The pediatric vaccine market is estimated to grow due to key factors such as the rising prevalence of chronic respiratory diseases, infectious diseases, and others among children. The market is also expected to grow due to the growing birth rate across the world. The vaccine market is expected to have growth opportunities in developing countries where the incidences of infectious diseases are more among children.

MARKET SCOPE

The "Global Pediatric Vaccine Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of pediatric vaccine market with detailed market segmentation by type, technology, application, and geography. The global pediatric vaccine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading pediatric vaccine market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global pediatric vaccine market is segmented on the basis of type, technology, and application. Based on the type the market is classified as monovalent, and multivalent. On the basis of technology the market is divided into live attenuated, inactivated, toxoid, conjugate, and other technologies. On the basis of application the market is segmented as infectious disease, allergy, and other applications.


REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global pediatric vaccine market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The pediatric vaccine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting pediatric vaccine market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the pediatric vaccine market in these regions.




Get more information on this report :

MARKET PLAYERS


The reports cover key developments in the pediatric vaccine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from pediatric vaccine market are anticipated to lucrative growth opportunities in the future with the rising demand for pediatric vaccine market in the global market. Below mentioned is the list of few companies engaged in the Pediatric vaccine market.

The report also includes the profiles of key pediatric vaccine market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Novartis AG
- AstraZeneca plc
- Sanofi
- Seqirus
- Pfizer Inc
- Merck and Co., Inc
- GlaxoSmithKline plc
- Serum Institute of India Pvt. Ltd
- Panacea Biotec Ltd.
- Eli Lilly and Company

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Pediatric Vaccine Market - By Type
1.3.2 Pediatric Vaccine Market - By Technology
1.3.3 Pediatric Vaccine Market - By Application
1.3.4 Pediatric Vaccine Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. PEDIATRIC VACCINE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. PEDIATRIC VACCINE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. PEDIATRIC VACCINE MARKET - GLOBAL MARKET ANALYSIS
6.1. PEDIATRIC VACCINE - GLOBAL MARKET OVERVIEW
6.2. PEDIATRIC VACCINE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. PEDIATRIC VACCINE MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. MONOVALENT
7.3.1. Overview
7.3.2. Monovalent Market Forecast and Analysis
7.4. MULTIVALENT
7.4.1. Overview
7.4.2. Multivalent Market Forecast and Analysis
8. PEDIATRIC VACCINE MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
8.1. OVERVIEW
8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. LIVE ATTENUATED
8.3.1. Overview
8.3.2. Live Attenuated Market Forecast and Analysis
8.4. INACTIVATED
8.4.1. Overview
8.4.2. Inactivated Market Forecast and Analysis
8.5. TOXOID
8.5.1. Overview
8.5.2. Toxoid Market Forecast and Analysis
8.6. CONJUGATE
8.6.1. Overview
8.6.2. Conjugate Market Forecast and Analysis
8.7. OTHER TECHNOLOGIES
8.7.1. Overview
8.7.2. Other Technologies Market Forecast and Analysis
9. PEDIATRIC VACCINE MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. INFECTIOUS DISEASE
9.3.1. Overview
9.3.2. Infectious Disease Market Forecast and Analysis
9.4. ALLERGY
9.4.1. Overview
9.4.2. Allergy Market Forecast and Analysis
9.5. OTHER APPLICATIONS
9.5.1. Overview
9.5.2. Other Applications Market Forecast and Analysis
10. PEDIATRIC VACCINE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Pediatric Vaccine Market Overview
10.1.2 North America Pediatric Vaccine Market Forecasts and Analysis
10.1.3 North America Pediatric Vaccine Market Forecasts and Analysis - By Type
10.1.4 North America Pediatric Vaccine Market Forecasts and Analysis - By Technology
10.1.5 North America Pediatric Vaccine Market Forecasts and Analysis - By Application
10.1.6 North America Pediatric Vaccine Market Forecasts and Analysis - By Countries
10.1.6.1 United States Pediatric Vaccine Market
10.1.6.1.1 United States Pediatric Vaccine Market by Type
10.1.6.1.2 United States Pediatric Vaccine Market by Technology
10.1.6.1.3 United States Pediatric Vaccine Market by Application
10.1.6.2 Canada Pediatric Vaccine Market
10.1.6.2.1 Canada Pediatric Vaccine Market by Type
10.1.6.2.2 Canada Pediatric Vaccine Market by Technology
10.1.6.2.3 Canada Pediatric Vaccine Market by Application
10.1.6.3 Mexico Pediatric Vaccine Market
10.1.6.3.1 Mexico Pediatric Vaccine Market by Type
10.1.6.3.2 Mexico Pediatric Vaccine Market by Technology
10.1.6.3.3 Mexico Pediatric Vaccine Market by Application
10.2. EUROPE
10.2.1 Europe Pediatric Vaccine Market Overview
10.2.2 Europe Pediatric Vaccine Market Forecasts and Analysis
10.2.3 Europe Pediatric Vaccine Market Forecasts and Analysis - By Type
10.2.4 Europe Pediatric Vaccine Market Forecasts and Analysis - By Technology
10.2.5 Europe Pediatric Vaccine Market Forecasts and Analysis - By Application
10.2.6 Europe Pediatric Vaccine Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Pediatric Vaccine Market
10.2.6.1.1 Germany Pediatric Vaccine Market by Type
10.2.6.1.2 Germany Pediatric Vaccine Market by Technology
10.2.6.1.3 Germany Pediatric Vaccine Market by Application
10.2.6.2 France Pediatric Vaccine Market
10.2.6.2.1 France Pediatric Vaccine Market by Type
10.2.6.2.2 France Pediatric Vaccine Market by Technology
10.2.6.2.3 France Pediatric Vaccine Market by Application
10.2.6.3 Italy Pediatric Vaccine Market
10.2.6.3.1 Italy Pediatric Vaccine Market by Type
10.2.6.3.2 Italy Pediatric Vaccine Market by Technology
10.2.6.3.3 Italy Pediatric Vaccine Market by Application
10.2.6.4 Spain Pediatric Vaccine Market
10.2.6.4.1 Spain Pediatric Vaccine Market by Type
10.2.6.4.2 Spain Pediatric Vaccine Market by Technology
10.2.6.4.3 Spain Pediatric Vaccine Market by Application
10.2.6.5 United Kingdom Pediatric Vaccine Market
10.2.6.5.1 United Kingdom Pediatric Vaccine Market by Type
10.2.6.5.2 United Kingdom Pediatric Vaccine Market by Technology
10.2.6.5.3 United Kingdom Pediatric Vaccine Market by Application
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Pediatric Vaccine Market Overview
10.3.2 Asia-Pacific Pediatric Vaccine Market Forecasts and Analysis
10.3.3 Asia-Pacific Pediatric Vaccine Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Pediatric Vaccine Market Forecasts and Analysis - By Technology
10.3.5 Asia-Pacific Pediatric Vaccine Market Forecasts and Analysis - By Application
10.3.6 Asia-Pacific Pediatric Vaccine Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Pediatric Vaccine Market
10.3.6.1.1 Australia Pediatric Vaccine Market by Type
10.3.6.1.2 Australia Pediatric Vaccine Market by Technology
10.3.6.1.3 Australia Pediatric Vaccine Market by Application
10.3.6.2 China Pediatric Vaccine Market
10.3.6.2.1 China Pediatric Vaccine Market by Type
10.3.6.2.2 China Pediatric Vaccine Market by Technology
10.3.6.2.3 China Pediatric Vaccine Market by Application
10.3.6.3 India Pediatric Vaccine Market
10.3.6.3.1 India Pediatric Vaccine Market by Type
10.3.6.3.2 India Pediatric Vaccine Market by Technology
10.3.6.3.3 India Pediatric Vaccine Market by Application
10.3.6.4 Japan Pediatric Vaccine Market
10.3.6.4.1 Japan Pediatric Vaccine Market by Type
10.3.6.4.2 Japan Pediatric Vaccine Market by Technology
10.3.6.4.3 Japan Pediatric Vaccine Market by Application
10.3.6.5 South Korea Pediatric Vaccine Market
10.3.6.5.1 South Korea Pediatric Vaccine Market by Type
10.3.6.5.2 South Korea Pediatric Vaccine Market by Technology
10.3.6.5.3 South Korea Pediatric Vaccine Market by Application
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Pediatric Vaccine Market Overview
10.4.2 Middle East and Africa Pediatric Vaccine Market Forecasts and Analysis
10.4.3 Middle East and Africa Pediatric Vaccine Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Pediatric Vaccine Market Forecasts and Analysis - By Technology
10.4.5 Middle East and Africa Pediatric Vaccine Market Forecasts and Analysis - By Application
10.4.6 Middle East and Africa Pediatric Vaccine Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Pediatric Vaccine Market
10.4.6.1.1 South Africa Pediatric Vaccine Market by Type
10.4.6.1.2 South Africa Pediatric Vaccine Market by Technology
10.4.6.1.3 South Africa Pediatric Vaccine Market by Application
10.4.6.2 Saudi Arabia Pediatric Vaccine Market
10.4.6.2.1 Saudi Arabia Pediatric Vaccine Market by Type
10.4.6.2.2 Saudi Arabia Pediatric Vaccine Market by Technology
10.4.6.2.3 Saudi Arabia Pediatric Vaccine Market by Application
10.4.6.3 U.A.E Pediatric Vaccine Market
10.4.6.3.1 U.A.E Pediatric Vaccine Market by Type
10.4.6.3.2 U.A.E Pediatric Vaccine Market by Technology
10.4.6.3.3 U.A.E Pediatric Vaccine Market by Application
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Pediatric Vaccine Market Overview
10.5.2 South and Central America Pediatric Vaccine Market Forecasts and Analysis
10.5.3 South and Central America Pediatric Vaccine Market Forecasts and Analysis - By Type
10.5.4 South and Central America Pediatric Vaccine Market Forecasts and Analysis - By Technology
10.5.5 South and Central America Pediatric Vaccine Market Forecasts and Analysis - By Application
10.5.6 South and Central America Pediatric Vaccine Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Pediatric Vaccine Market
10.5.6.1.1 Brazil Pediatric Vaccine Market by Type
10.5.6.1.2 Brazil Pediatric Vaccine Market by Technology
10.5.6.1.3 Brazil Pediatric Vaccine Market by Application
10.5.6.2 Argentina Pediatric Vaccine Market
10.5.6.2.1 Argentina Pediatric Vaccine Market by Type
10.5.6.2.2 Argentina Pediatric Vaccine Market by Technology
10.5.6.2.3 Argentina Pediatric Vaccine Market by Application
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. PEDIATRIC VACCINE MARKET, KEY COMPANY PROFILES
12.1. NOVARTIS AG
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ASTRAZENECA PLC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. SANOFI
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. SEQIRUS
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. PFIZER INC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MERCK AND CO., INC
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. GLAXOSMITHKLINE PLC
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SERUM INSTITUTE OF INDIA PVT. LTD
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. PANACEA BIOTEC LTD.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. ELI LILLY AND COMPANY
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Novartis AG
2. AstraZeneca plc
3. Sanofi
4. Seqirus
5. Pfizer Inc
6. Merck and Co., Inc
7. GlaxoSmithKline plc
8. Serum Institute of India Pvt. Ltd
9. Panacea Biotec Ltd.
10. Eli Lilly and Company
TIPRE00008681
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking